CClinicalTrials.gg
CompletedNCT02874196PLIDETUpdated Aug 22, 2016

Prosthesis Loosening Imaging With Dual Energy and Tomosynthesis

An interventional study of Standard arthrography and Dual energy arthrography in Hip Prosthesis Imaging, sponsored by Central Hospital, Nancy, France. Completed at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-08-22.

Sponsored by Central Hospital, Nancy, France · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose is to determine diagnostic performances of flat panel dual energy arthrography and arthro-tomosynthesis in identification of loosening of painful hip prosthesis, taking as reference the results of surgery performed 6 months after arthrography.

Secondary purposes are:

  • To describe the level of concordance of each technique with the indication for surgery
  • To study inter-technique concordance with kappa coefficient
  • To study the relationship between density differential between 2 acquisitions and grey level on subtraction, i.e. subtraction quality according to metal
Read the detailed description

Hip arthroplasty has become one of the most performed orthopedic procedures. Actual average lifetime of total hip prosthesis is approximately 15 years. Some complications are inevitable. Total hip prosthesis imaging, performed to search for a complication or wear, is difficult and depends on many techniques. Subtracted arthrography is a good technique but its access is limited because it needs an angiography room.

In this study patients undergo standard arthrography, dual energy arthrography, arthro-tomosynthesis and arthro-tomography.

02

Conditions studied

  • Hip Prosthesis Imaging
03

In context

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients sent for arthro-tomography of painful prosthesis, without contraindications to arthrography or injection of contrast agent
  • Aware and cooperative
  • Signed informed consent
  • Affiliation to social security

Exclusion criteria

Exclusion Criteria:

  • Any contraindication to arthrography or injection of contrast agent
  • Pregnant or possibly pregnant women
  • Patient under guardianship
  • Refusal or impossibility of informed consent
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
66 participants (actual)

Study arms

  • Experimental
    Patients with painful prosthesis

    Procedure: Standard arthrography · Procedure: Dual energy arthrography · Procedure: Arthro-tomosynthesis · Procedure: Arthro-tomography · Procedure: Surgery on painful prosthesis

Interventions

  • ProcedureStandard arthrography
  • ProcedureDual energy arthrography
  • ProcedureArthro-tomosynthesis
  • ProcedureArthro-tomography
  • ProcedureSurgery on painful prosthesis

    Possibly performed during 6 months from arthrography

06

What researchers measure

Primary outcomes

  1. Presence or absence of prosthesis loosening detected with 3 radiographic techniques (dual-energy arthrography, arthro-tomosynthesis and single-energy tomography) and surgery

    Gold standard is presence or absence of prosthesis loosening revealed with surgery performed after 6 months from arthrography. Data of patients undergone surgery and not are collected and analyzed. Any clinical or imagery sign of loosening in non-operated patient, will be classified as loosening. A surgery decision for suspicion of loosening will be considered loosening.

    Time frame: from day 0 up to 6 months

Secondary outcomes

  1. Comparison between density differential between 2 acquisitions and grey level on subtraction

    Time frame: day 0

07

Study locations

2 sites
  • CHU de Nancy
    Nancy, France
  • SINCAL
    Nancy, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02874196
Lead sponsor
Central Hospital, Nancy, France
Responsible party
Sponsor
First posted
Aug 22, 2016
Start date
Jul 2012
Primary completion
Sep 2015
Completion
Sep 2015
Last update
Aug 22, 2016

Study contacts

Alain Blum
principal investigator · Service d'Imagerie Guilloz - CHU Nancy - France

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion